TRAC and melanoma: Thus, we generated CD8+ T cell avatars reactive to IGRP265-273 (7) and targeted the TCRα chain constant (TRAC) region via CRISPR/Cas9 (Figure 1A), as has been previously reported to improve on-target efficacy of avatars specific for a melanoma antigen (22).